HPLC 2026
JW Marriott, Indianapolis | Booth #105 | June 6 - 11
DIAMOND SPONSOR
Chromatography Innovation, Delivered.
Sean Orlowicz
Principal Market Developmenz Manager – Pharma Phenomenex
LUNCH SEMINAR
Assay to Aggregates: Chromatographic Workflows for Therapeutic Peptides and Their Unique Impurities
Monday, June 8 | 12:30 PM - 1:30 PM
White River E
Overview
Therapeutic peptides are a rapidly growing drug class that present unique analytical and chromatographic challenges, requiring advanced strategies to accurately separate and characterize closely related impurities, degradation products, and higher‑order species.
What You’ll Learn
- Key analytical challenges in therapeutic peptide characterization
- Strategies for separating closely related impurities and degradation products
- Approaches to analyzing higher‑order and aggregated peptide species
- Complementary chromatographic workflows for peptide analysis
- Practical assay, impurity/related‑substances, and aggregation methods for modern pharma labs
Sean Orlowicz is a seasoned professional with over 23 years of experience in chromatography, LC‑MS, and method development. Since joining Phenomenex in 2003, he has supported global clients, led the company’s applications laboratory, and driven innovation across multiple market segments. Sean now serves as the Principal Market Development Manager for Pharma, guiding global strategy for Phenomenex’s largest market.
POSTER SESSIONS
10 AM - 11 AM and 3 PM - 4:30 PM | JUNE 8 - 11 | Griffin Hall
Meet our scientific experts and learn about the latest advances in separation science with insights you can apply directly to your lab.
POSTER
PRESENTER
DATE / TIME
POSTER/TALK #
(Oral Presentation)
Impact of Column Hardware Systems on (U)HPLC Column Performance
Director – Research and Open Innovation, Phenomenex
Monday, June 8
2:40 pm – 3 pm
61
(Oral Presentation)
Chemo- and enantioselectivity with polysaccharide-based chiral selectors, a unique solution to challenging separations for closely related (chiral) compounds
Senior Managing Scientist, Phenomenex
Tuesday, June 9
5:00 pm – 5:20 pm
156
Retention and Efficiency Improvements in HILIC with a Modified Silica Diol Phase
Product Manager, Phenomenex
Monday, June 8
10:00 am – 11:00 am
214
Modernization of USP Methods Using Core-Shell Columns: Improved Efficiency and Throughput for Nifedipine and Flurbiprofen
Technical Specialist, Phenomenex
Monday, June 8
3:00 pm – 4:30 pm
242
Improved Column Lifetime in Biological Matrices Using Novel Hardware Technology for LC-MS/MS Analysis
Technical Specialist, Phenomenex
Monday, June 8
10:00 am – 11:00 am
241
Integrated Assay and Stability Indicating HPLC Methods for Semaglutide Using a Core Shell Peptide Column
Principal Market Development Manager - Pharmaceutical, Phenomenex
Monday, June 8
3:00 pm – 4:30 pm
244
Aggregate Analysis of Common GLP-1s
Principal Market Development Manager - Pharmaceutical, Phenomenex
Monday, June 8
10:00 am – 11:00 am
247
Separation and Identification of Individual Intact Antibody–Drug Conjugates by Native Reverse Phase‑LC–MS
Senior R&D Manager, Phenomenex
Tuesday, June 9
3:00 pm – 4:30 pm
219
Characterization of N-Glycan species of VEGF decoy receptor fusion protein by BioZen Glycan HILIC separation with high sensitive mass spectrometric analysis
Senior Product Manager, SCIEX
Tuesday, June 9
10:00 am – 11:00 am
300
A LC-MS Ready Size Exclusion Chromatographic Platform Method for Oligonucleotide and mRNA Identification
Senior Director, Global Marketing & GC Business Unit Manager, Phenomenex
Tuesday, June 9
10:00 am – 11:00 am
182
Systematic LC Method Development: A Case Study on Mupirocin
Global Marketing, Phenomenex
Wednesday, June 10
10:00 am – 11:00 am
195
Improved Sensitivity and Selectivity for Ultra‑Short-Chain PFAS in Tomatoes Using LC‑MS/MS Analysis
Product Manager, Phenomenex
Wednesday, June 10
10:00 am – 11:00 am
197
Development of an LC-MS/MS method for quantitation of insulin degludec in rat plasma
Chris Leitner - SCIEX
Senior Territory Manager
Monday, June 8
3:00 pm – 4:30 pm
274
Future-proof LC-MS/MS solution for analysis of nitrosamines in esomeprazole API
Anna Smallwood - SCIEX
Product Manager
Monday, June 8
3:00 pm – 4:30 pm
275
Quantitation of N-nitroso sitagliptin impurity (NTTP) in sitagliptin API - Targeted and Untargeted analysis track
Tilak Chandrasekaran -SCIEX
Market Development Manager, Pharmaceutical
Monday, June 8
3:00 pm – 4:30 pm
276
